1 suspended, 1 withdrawn. 2 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 2 | Suspended 1, Withdrawn 1 |
Follow Sclerosis: new trials by email Literature Review of Sclerosis trials Research Report on Sclerosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of RD06-04 in Patients With Active Autoimmune Diseases RD06-04 cell infusion - SLE, Sclerosis | Early Phase 1 | Withdrawn | Nanjing Bioheng Biotech Co., Ltd. | 2024-08-31 | 2026-02-03 | |
| Allogeneic Mesenchymal Stem Cell-Derived Exosome Therapy for Progressive Multiple Sclerosis MSC-Derived Exosomes, Placebo (Normal Saline) - Multiple Sclerosis | Early Phase 1 | Suspended | Biocells Medical | 20 | 2020-07-01 | 2025-08-28 |
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (1) · Multiple Sclerosis (1) · Neuromyelitis Optica (1)
Autoimmune Diseases (2) · Autoimmune Diseases of the Nervous System (2) · Demyelinating Autoimmune Diseases, CNS (2) · Demyelinating Diseases (2) · Immune System Diseases (2) · Nervous System Diseases (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Cardiovascular Diseases (1) · Cranial Nerve Diseases (1) · Eye Diseases (1) · Myelitis, Transverse (1) · Optic Nerve Diseases (1) · Optic Neuritis (1) · Skin Diseases (1)
Saline Solution (1)
Biocells Medical (1) · Nanjing Bioheng Biotech Co., Ltd. (1)
China (1) · Poland (1)